Armata Pharmaceuticals ARMP Q2 2026 earnings

FAQ

When did Armata Pharmaceuticals report Q2 2026 earnings?

Armata Pharmaceuticals (ARMP) reported Q2 2026 earnings on August 12, 2026 after market close.

What were Armata Pharmaceuticals's Q2 2026 revenue and EPS?

Armata Pharmaceuticals reported revenue of $2.5M and eps of $-0.27 for Q2 2026.

Did Armata Pharmaceuticals beat estimates in Q2 2026?

Revenue beat the consensus estimate of $400.0K by $2.1M. EPS beat the consensus estimate of $-0.45 by $0.17.

How did Armata Pharmaceuticals's Q2 2026 results compare year-over-year?

Compared to the same quarter a year prior, revenue grew 15.7% from $2.2M a year earlier and eps grew 15.6% from $-0.32.

Where can I find Armata Pharmaceuticals's Q2 2026 SEC filings?

You can read the 8-K earnings release (0001104659-26-094896) and the 10-Q periodic report (0001104659-26-094907) directly on SEC EDGAR. The filing index links above go to sec.gov.